Urinary Biomarkers in Parkinson’s Disease: A Structured Integrative Review of Pathophysiological Pathways
Medical Sciences · 17.05.2026 · 14 (2) · 258
DOI: 10.3390/medsci14020258 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Medical Sciences, online erschienen am 17.05.2026. Verfasst von Halyne Queiroz Pantaleão Santos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Natural and Humanities Sciences Center (CCNH), Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), São Bernardo do Campo 096…. Hauptthemen laut MEDLINE: Parkinson Disease, Biomarkers. Die Arbeit nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: State of São Paulo Research Foundation, Coordination for the Improvement of Higher Education Personnel.
Abstract (Originalsprache)
Background/Objectives: Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by complex and interconnected pathophysiological mechanisms, including mitochondrial dysfunction, oxidative stress, neuroinflammation, lysosomal impairment, and altered neurotransmitter metabolism. Unlike cerebrospinal fluid or blood, urine offers a truly non-invasive source of biomarkers, reflecting systemic metabolic changes and renal protein excretion linked to neurodegeneration. This review aims to critically synthesize current evidence on urinary biomarkers in PD and to organize this heterogeneous literature into pathophysiologically meaningful domains.
Methods
A comprehensive literature search of human studies investigating urinary biomarkers in PD was performed. Eligible studies were comprehensively analyzed and classified according to dominant biological pathways. To facilitate interpretation, findings were organized into six thematic domains: genetic and protein-based biomarkers; metabolic pathways and mitochondrial dysfunction; oxidative stress and neuroinflammation; gut–brain-axis-related metabolites; hormonal and systemic biomarkers; and emerging exploratory markers. Results were summarized in domain-specific tables and integrated using a conceptual framework.
Results
A total of 32 human studies met the inclusion criteria, revealing diverse urinary molecular signatures associated with PD across multiple biological domains. Genetic and protein-based markers, including LRRK2-related proteins, α-synuclein species, and lysosomal lipids, showed potential for disease stratification. Metabolomic studies consistently identified alterations in acylcarnitines, organic acids, and amino acid metabolism, reflecting mitochondrial dysfunction. Biomarkers related to oxidative stress, immune activation, gut microbiota metabolism, and hormonal regulation further highlighted the systemic nature of PD. However, most individual biomarkers lacked disease specificity and exhibited methodological heterogeneity.
Conclusions
Current evidence supports urine as a valuable source of systemic biomarkers reflecting multiple pathophysiological processes in PD. While single urinary markers remain insufficient for clinical application, integrated omics-based approaches—particularly metabolomics and peptidomics/proteomics—hold promise for identifying combinatorial biomarker signatures. Future longitudinal and standardized studies are required to enhance specificity and translational potential for non-invasive diagnosis and disease monitoring in PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Natural and Humanities Sciences Center (CCNH), Experimental Morphophysiology Laboratory, Federal University of ABC (UFABC), São Bernardo do Campo 09606-070, SP, Brazil.
- Central Laboratory Division, Hospital das Clínicas da Faculdade de Medicina, Universidade de São Paulo (HCFMUSP), LIM-03, São Paulo 05403-010, SP, Brazil.
- Mathematics, Computation and Cognition Center (CMCC), Federal University of ABC (UFABC), São Bernardo do Campo 09606-070, SP, Brazil.
ORCID-Profile: Carlos Alberto-Silva
Förderung
- State of São Paulo Research Foundation
- Coordination for the Improvement of Higher Education Personnel
Zitieren
APA
Santos, H. Q. P., Sumita, N. M., Alberto-Silva, C., & Echeverry, M. B. (2026). Urinary Biomarkers in Parkinson’s Disease: A Structured Integrative Review of Pathophysiological Pathways. Medical Sciences, 14(2), 258. https://doi.org/10.3390/medsci14020258
Vancouver
Santos HQP, Sumita NM, Alberto-Silva C, Echeverry MB. Urinary Biomarkers in Parkinson’s Disease: A Structured Integrative Review of Pathophysiological Pathways. Medical Sciences. 2026;14(2):258. doi:10.3390/medsci14020258
BibTeX
@article{Santos2026,
author = {Santos, Halyne Queiroz Pantaleão and Sumita, Nairo Massakazu and Alberto-Silva, Carlos and Echeverry, Marcela Bermudez},
title = {Urinary Biomarkers in Parkinson’s Disease: A Structured Integrative Review of Pathophysiological Pathways},
journal = {Medical Sciences},
year = {2026},
volume = {14},
number = {2},
pages = {258},
doi = {10.3390/medsci14020258}
}
EUVIMED